IMMERSE: Innovative Malaria M&E, Research and Surveillance towards Elimination: S

沉浸：创新型疟疾 M

• 批准号: 9213069
• 负责人: Sylvia Meek
• 金额: $ 27.88万
• 依托单位: MALARIA CONSORTIUM
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-01 至 2018-08-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9213069
• 关键词: IMMERSE; Innovative; Malaria; M&E; Research

DESCRIPTION (provided by applicant): The aim of this program is to improve malaria program implementation in the Greater Mekong Sub-region (GMS) (with a particular focus on Myanmar, Cambodia and Thailand), and build a robust and reliable evidence platform capable of developing and evaluating operational research, surveillance, and monitoring & evaluation (M&E) activities to inform policies and practices in conjunction with national malaria control programs and other partners. The specific aims are as follows: Develop and refine M&E and surveillance tools in order to assess the impact of existing interventions, monitor short-term malaria burden and transmission trends and inform programs on when to move from control to elimination strategies. To monitor artemisinin and artemisinin combination therapy ACT resistance using innovative approaches to conduct a series of OR activities to assess country-specific feasibility of malaria active case detection interventions, evaluation of innovative delivery mechanisms to target hard to reach populations and point of care diagnostics. Promote use of knowledge by local and national policy makers and program planners ensuring strategic information is disseminated and shared among GMS and sub-Saharan Africa (SSA), and best practices harmonized in the region. The principal approach will be to strengthen national programs capacity to move from malaria control to elimination and to support artemisinin resistance containment through the implementation and use of robust and innovative M&E, surveillance, and operational research. Malaria Consortium works closely with national malaria programs and partners through provision of technical assistance and implementation support. We shall focus on operationalizing the useful tools and promoting their uptake. In addition to its own team MC will engage key technical assistance from London School of Hygiene & Tropical Medicine and Institute Pasteur in Cambodia as well as some independent consultants, and if savings are made, MC will also engage Health Poverty Action for work in the special regions of eastern Burma. We shall work in strong collaboration with CDC and with WHO, and shall provide technical support also when needed to other PMI supported programs. By the end of the program we expect that a much higher standard of surveillance will be fully operational in partner countries, and key responses to malaria problem areas will be designed and implemented.

描述（由申请人提供）： 该计划的目的是改善大湄公河次区域（GMS）（特别关注缅甸、柬埔寨和泰国）的疟疾计划实施，并建立一个能够开发和评估业务研究的强大而可靠的证据平台，监测、监测和评估 (M&E) 活动，以便与国家疟疾控制规划和其他合作伙伴一起为政策和实践提供信息。具体目标如下：开发和完善监测、评估和监测工具，以评估现有干预措施的影响，监测短期疟疾负担和传播趋势，并告知规划何时从控制战略转向消除战略。为了监测青蒿素和青蒿素联合疗法的 ACT 耐药性，使用创新方法开展一系列 OR 活动，以评估疟疾主动病例检测干预措施的具体国家可行性、评估针对难以接触人群的创新递送机制以及护理点诊断。促进地方和国家决策者以及项目规划者对知识的利用，确保战略信息在大湄公河次区域和撒哈拉以南非洲地区（SSA）之间传播和共享，并在该地区协调最佳实践。主要方法是加强国家规划能力，从疟疾控制转向消除疟疾，并通过实施和使用强有力和创新的监测和评估、监测和业务研究来支持遏制青蒿素耐药性。疟疾联盟通过提供技术援助和实施支持与国家疟疾规划和合作伙伴密切合作。我们将重点关注有用工具的运作并促进其采用。除了自己的团队外，MC还将聘请伦敦卫生与热带医学学院和柬埔寨巴斯德研究所以及一些独立顾问提供关键技术援助，如果节省下来，MC还将聘请健康贫困行动组织开展专门的工作。缅甸东部地区。我们将与 CDC 和 WHO 密切合作，并在需要时为其他 PMI 支持的项目提供技术支持。到该计划结束时，我们预计伙伴国家将全面实施更高标准的监测，并将设计和实施针对疟疾问题领域的关键应对措施。